Sciatica And Its Management Through Ayurveda

A CLINICAL STUDY OF RAKTMOKSHANA AND VAJIGANDHADI TAILA MATRA BASTI IN GRIDHARSI W.S.R.SCIATICA

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/031737

Enrollment

Registered

2021-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

Intervention1: Vajigandhadi Matra Basti and Siravedhan: GROUP A-Vajigandhadi Matra Basti for 15 days. GROUP B-SIRAVEDHAN about 50 to 150 ml of blood is letted. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with uncomplicated sciatica. 2. Sciatica due to L4-L5-S1 lumber disc degenerative disease.

Exclusion criteria

Exclusion criteria: 1.Patients with severe renal and cariac disease,Malignancy,Infectious condition of spine,severe anaemic,specific fever like dengue. 2.pregnant woman. 3.Patient who have lost the control on bowel and bladder. 4.Trauma.

Design outcomes

Primary

Measure	Time frame
Improvement in subjective and objective parametersTimepoint: 15days	—

Secondary

Measure	Time frame
To find out the comparative efficacy of the treatment in both the groupsTimepoint: 15 days	—

Countries

India

Contacts

Public ContactDR SURABHI NEMIWAL

DSRRAU,JODHPUR

atreyagyan@gmail.com9829798701

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026